Jeffrey W. Jacobs, Chief Scientific Officer at ARDELYX, INC. (ARDX), sold 741 shares at $1.32 ($978) on 2021-08-20, disclosed to the SEC on 2021-08-24.
Open-market sale of $978 ARDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARDX | SELL | 2021-11-10 | $3K | — | Filing → |
| ARDX | SELL | 2021-06-17 | $55K | — | Filing → |
| ARDX | SELL | 2021-05-21 | $5K | — | Filing → |